Cargando…
Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes
BACKGROUND: In previous research, we found diabetes rather than obesity was an independent risk factor of breast cancer. However, why diabetes could lead to increased risk of breast cancer patients remains elusive. Long non‐coding RNAE330013P06 has been shown to be upregulated in diabetes, and long...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246379/ https://www.ncbi.nlm.nih.gov/pubmed/31907990 http://dx.doi.org/10.1002/jcla.23172 |
_version_ | 1783537932205817856 |
---|---|
author | Chen, Runqi Shi, Pengcheng Zhang, Yan Wu, Haiming Li, Xiaoping Yang, Wengfu Luo, Fei JinmingXue, Yao, Liang Yang, Jun Wang, Wangfu Zhang, Bo Li, Peng Miao, Yongmin Wang, Qianjun Tian, Fuguo |
author_facet | Chen, Runqi Shi, Pengcheng Zhang, Yan Wu, Haiming Li, Xiaoping Yang, Wengfu Luo, Fei JinmingXue, Yao, Liang Yang, Jun Wang, Wangfu Zhang, Bo Li, Peng Miao, Yongmin Wang, Qianjun Tian, Fuguo |
author_sort | Chen, Runqi |
collection | PubMed |
description | BACKGROUND: In previous research, we found diabetes rather than obesity was an independent risk factor of breast cancer. However, why diabetes could lead to increased risk of breast cancer patients remains elusive. Long non‐coding RNAE330013P06 has been shown to be upregulated in diabetes, and long non‐coding RNAs generally promote progression of cancer. METHODS: About 200 specimens of breast patients were obtained in previous clinical trial; 34 samples diagnosed as type 2 diabetes in breast cancer patient were enrolled in this research. Blood samples from 36 patients diagnosed as breast cancer without diabetes; 35 diabetic patients and 35 healthy peoples were obtained as control. All blood samples were measured by quantitative real‐time PCR (qRT‐PCR). Invasion and migration were tested by Transwell assay. Cell proliferation assay was tested by CCK‐8. Protein analysis was determined by Western blot. RESULTS: Compared with breast cancer patients without diabetes, diabetic patients without breast cancer and healthy peoples, LncRNAE330013P06 was upregulated in breast cancer patient with diabetes. Furthermore, of 34 breast patients, high LncRNAE330013P06 expression was significantly associated with family history, tumor‐node‐metastasis stage and lymph node metastasis. E33 promoted cancer cell growth in vitro via downregulation of P53. CONCLUSION: Upregulation of LncRNAE330013P06 driven by type 2 diabetes is one of the factors which promoted progression of breast cancer. |
format | Online Article Text |
id | pubmed-7246379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72463792020-06-01 Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes Chen, Runqi Shi, Pengcheng Zhang, Yan Wu, Haiming Li, Xiaoping Yang, Wengfu Luo, Fei JinmingXue, Yao, Liang Yang, Jun Wang, Wangfu Zhang, Bo Li, Peng Miao, Yongmin Wang, Qianjun Tian, Fuguo J Clin Lab Anal Research Articles BACKGROUND: In previous research, we found diabetes rather than obesity was an independent risk factor of breast cancer. However, why diabetes could lead to increased risk of breast cancer patients remains elusive. Long non‐coding RNAE330013P06 has been shown to be upregulated in diabetes, and long non‐coding RNAs generally promote progression of cancer. METHODS: About 200 specimens of breast patients were obtained in previous clinical trial; 34 samples diagnosed as type 2 diabetes in breast cancer patient were enrolled in this research. Blood samples from 36 patients diagnosed as breast cancer without diabetes; 35 diabetic patients and 35 healthy peoples were obtained as control. All blood samples were measured by quantitative real‐time PCR (qRT‐PCR). Invasion and migration were tested by Transwell assay. Cell proliferation assay was tested by CCK‐8. Protein analysis was determined by Western blot. RESULTS: Compared with breast cancer patients without diabetes, diabetic patients without breast cancer and healthy peoples, LncRNAE330013P06 was upregulated in breast cancer patient with diabetes. Furthermore, of 34 breast patients, high LncRNAE330013P06 expression was significantly associated with family history, tumor‐node‐metastasis stage and lymph node metastasis. E33 promoted cancer cell growth in vitro via downregulation of P53. CONCLUSION: Upregulation of LncRNAE330013P06 driven by type 2 diabetes is one of the factors which promoted progression of breast cancer. John Wiley and Sons Inc. 2020-01-06 /pmc/articles/PMC7246379/ /pubmed/31907990 http://dx.doi.org/10.1002/jcla.23172 Text en © 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Chen, Runqi Shi, Pengcheng Zhang, Yan Wu, Haiming Li, Xiaoping Yang, Wengfu Luo, Fei JinmingXue, Yao, Liang Yang, Jun Wang, Wangfu Zhang, Bo Li, Peng Miao, Yongmin Wang, Qianjun Tian, Fuguo Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes |
title | Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes |
title_full | Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes |
title_fullStr | Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes |
title_full_unstemmed | Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes |
title_short | Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes |
title_sort | long non‐coding rnae330013p06 promotes progression of breast cancer with type 2 diabetes |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246379/ https://www.ncbi.nlm.nih.gov/pubmed/31907990 http://dx.doi.org/10.1002/jcla.23172 |
work_keys_str_mv | AT chenrunqi longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT shipengcheng longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT zhangyan longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT wuhaiming longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT lixiaoping longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT yangwengfu longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT luofei longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT jinmingxue longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT yaoliang longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT yangjun longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT wangwangfu longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT zhangbo longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT lipeng longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT miaoyongmin longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT wangqianjun longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes AT tianfuguo longnoncodingrnae330013p06promotesprogressionofbreastcancerwithtype2diabetes |